Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

European Science Champions Score an Early Goal for Cloud Computing

11.07.2012
‘Helix Nebula – the science cloud’, set up earlier this year to support the massive IT requirements of European scientists and create a cloud computing market for the public sector in Europe, has today announced the initial deployment of its first flagship applications in high energy physics, molecular biology and natural disaster risk management.

A collaboration between big science and big business, Helix Nebula joins the forces of leading IT providers and three of Europe’s leading research centres (CERN*, EMBL**, and ESA***), and has now received €1.8 million funding from the European Commission.

The initiative strongly supports the Commission’s Digital Agenda for Europe: It stresses a unified approach to data protection regulations and lightweight, efficient governance; it also has ambitions to support European economic development by making its services available to the wider community.

First results of the initiative’s on-going Proof of Concept (PoC) phase now show that CERN, EMBL and ESA succeeded in deploying challenging scientific applications each involving tens of thousands of jobs running at data centres operated by Atos, CloudSigma and T-Systems.

By getting the ATLAS experiment’s flagship application deployed quickly, CERN was able to run simulations that had previously been executed on the Worldwide LHC Computing Grid, helping to build the case for the recent announcement related to the Higgs boson search. “These initial deployments have confirmed that building a multi-tenant, multi-provider public cloud infrastructure is a massive undertaking that will need a number of steps to complete. However, the first results are very encouraging and we are confident we can reach our goal during the two year pilot phase,” said Frédéric Hemmer, Head of CERN’s IT Department.

EMBL’s team successfully deployed and tested their novel software pipeline for large-scale genomic analysis on the different cloud provider infrastructures. Using real world large genomic data sets originating from EMBL’s sequencing machines, EMBL’s PoC extensively evaluated key elements such as scalability, performance and on-demand provisioning of resources for high performance computing and fast data storage in these clouds. Paul Flicek, Head of Vertebrate Genomics at EMBL's European Bioinformatics Institute explained: “Setting up sufficiently powerful computing infrastructures for genome analysis in the cloud is not trivial. Hence, we are very happy with the initial results from the PoC. These are important milestones towards making our software available to scientists worldwide later during the Helix Nebula pilot phase.”

“ESA has successfully tested large-scale data processing and dissemination from its radar satellites (ERS, Envisat) using different cloud provider infrastructures. The results have demonstrated that these applications can run on multiple providers, despite using different technologies. Thanks to these cloud assets and the modern communication tools, the global science community will be able to better exploit ESA’s large-scale data archive covering 20 years of Earth Observation and foster collaboration of science communities working in different domains,” commented Volker Liebig, Director for ESA Earth Observation Programmes.

Atos, CloudSigma and T-Systems have provided the cloud computing resources to host the flagships and were instrumental during this PoC phase.

Atos has been active in opening up its existing cloud services to research organizations. Michael Symonds, its Principal Solutions Architect, confirmed that: “Setting up a public style cloud for very demanding research organisations is very different to providing private enterprise cloud services to companies. It has taken a lot of effort but we are all pleased with these early results and are confident we can build on this in the future.”

Robert Jenkins, CTO of CloudSigma, which already operates a public cloud service, said: “Not only does this early success show we are on the right track but it is also helping us identify new business opportunities for cloud services in the public sector that we hope to develop during this pilot phase.”

Jurry de la Mar, Head of International Sales – Public Sector at T-Systems, the company which has been driving the work to define the governance model for this public-private partnership, concluded: “Like any successful team, we needed a small core to get things going. During 2012 we will be studying how to expand the consortium membership to include more suppliers, more applications and more public sector organisations.”

In addition to the infrastructure providers, SME’s such as SixSq, Terradue and The Server Labs were vital to get the flagship applications up and running. More scientific organisations and service providers are welcome to join Helix Nebula- the Science Cloud.

Helix Nebula current participants are: Atos, Capgemini, CERN, CloudSigma, Cloud Security Alliance, CNES, CNR IRIA, DLR, EMBL, ESA, European Grid Infrastructure, Interoute, Logica, the OpenNebula Project, Orange Business Services, SAP, SixSq, Telefonica, Terradue, Thales, The Server Labs, Trust-IT, and T-Systems.

For more details and updates about Helix Nebula - the Science Cloud, please consult our website, visit us on Facebook, follow us on Twitter or send an email to contact@helix-nebula.eu.

Contacts:
CERN Press Office
+41 (0)22 767 34 32
+41 (0)22 767 21 41
press.office@cern.ch
EMBL press contact
Lena Raditsch
Head of Communications and Public Relations
+49 62213878125
lena.raditsch@embl.de
ESA press contact
Dr. Maryline Lengert
Senior Advisor
+39 06 941 80430
maryline.lengert@esa.int
Follow CERN at:
• www.cern.ch
• http://twitter.com/cern/
• http://www.youtube.com/user/CERNTV
• http://www.quantumdiaries.org/
Footnotes:
*CERN, the European Organization for Nuclear Research, is the world's leading laboratory for particle physics. It has its headquarters in Geneva. At present, its Member States are Austria, Belgium, Bulgaria, the Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Italy, the Netherlands, Norway, Poland, Portugal, Slovakia, Spain, Sweden, Switzerland and the United Kingdom. Romania is a candidate for accession. Israel and Serbia are Associate Members in the pre-stage to Membership. India, Japan, the Russian Federation, the United States of America, Turkey, the European Commission and UNESCO have Observer status.
**The European Molecular Biology Laboratory (EMBL) is a basic research institute sponsored by public research funding from 20 member states (Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom) and associate member state Australia. Research at EMBL is conducted by approximately 85 independent groups covering molecular biology. The laboratory has five units: the main laboratory in Heidelberg, outstations in Hinxton (the European Bioinformatics Institute), Grenoble, Hamburg, and Monterotondo near Rome. The cornerstones of EMBL's mission are: to perform basic research in molecular biology; to train scientists, students and visitors at all levels; to offer vital services to scientists in Member States; to develop new instruments and methods in the life sciences, and to actively engage in technology transfer activities. Around 190 students are enrolled in EMBL's International PhD programme. Additionally, the laboratory offers a platform for dialogue with the general public through various science communication activities such as lecture series, visitor programmes and the dissemination of scientific achievements.

***The European Space Agency (ESA) is Europe's gateway to space. Its mission is to shape the development of Europe's space capability and ensure that investment in space continues to deliver benefits to the citizens of Europe and the world. ESA is an international organisation with 19 Member States. By coordinating the financial and intellectual resources of its members, it can undertake programmes and activities far beyond the scope of any single European country. ESA's job is to draw up the European space programme and carry it through. ESA's programmes are designed to find out more about Earth, its immediate space environment, our Solar System and the Universe, as well as to develop satellite-based technologies and services, and to promote European industries. ESA also works closely with space organisations outside Europe.

CERN Press Office | Newswise Science News
Further information:
http://www.cern.ch
http://www.embl.de
http://www.esa.int

More articles from Information Technology:

nachricht Multifunctional e-glasses monitor health, protect eyes, control video game
28.05.2020 | American Chemical Society

nachricht Researchers incorporate computer vision and uncertainty into AI for robotic prosthetics
28.05.2020 | North Carolina State University

All articles from Information Technology >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

German-British Research project for even more climate protection in the rail industry

28.05.2020 | Transportation and Logistics

A special elemental magic

28.05.2020 | Physics and Astronomy

Skoltech scientists get a sneak peek of a key process in battery 'life'

28.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>